- 360 WallStreet
- Posts
- This SPAC is unlocking the future of pregnancy care
This SPAC is unlocking the future of pregnancy care
It's soaring today!
Ends Thursday š„ I MM Chat
Good day, 360!
Hereās a special invitation to join the Market Masterās Chat Room ALL day for trading (complimentary).
And see the SPECIAL insert below for the SMALL ACCOUNT JOURNEY sale ending tomorrow. Jason is on š„. Be the best prepared trader on the Street!
FOCUS LISTš
LGVC - Up over 100% in the pre-market after SPAC business combination with Nuvo approved by shareholders
HSDT - Up over 35% in pre after partnership with LovellĀ® Government Services to expand the reach of PoNS Therapyā¢, a multiple sclerosis(MS) treatment
KTRA - Up over 100% in pre after entering into a definitive merger agreement with TuHURA Biosciences
šHURRY š
Sale Ends Thursday
Save up to 45% on Small Account Journey
Join and Jason will teach you his 4 step process heās using to grow a small $2,000 balance.
Heās won 63 straight trades with this 4 step process and his current $2,000 balance has a 93% win rate on 134 trades.
Results not typical. Trading is hard. Nothing is guaranteed.
Subscribers can look over Jasonās shoulder in real time as he uses this 4 step process in his boldest mission ever to turn $2,000 into $100,000.
Save $502 - $2,002 on subscriptions and plans when you join today.
But hurry, the up to 45% savings ends Thursday.
ā START YOUR JOURNEY ā
HOTLISTš„
LGVC - Up over 100% in the pre-market after SPAC business combination with Nuvo approved by shareholders
LAMF Global Ventures Corp (LGVC) is a SPAC. It does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
In the after-hours yesterday, the company announced that shareholders voted to approve the previously announced business combination between LGVC and Nuvo, a limited liability company organized under the laws of the State of Israel
Nuvo is committed to reinventing pregnancy care for the 21st century through new technology, tools, and practices for providers and expectant mothers, including the INVU by Nuvoā¢ platform, an FDA-cleared, prescription-initiated remote pregnancy monitoring and management system.
The INVUā¢ sensor band enables the delivery of remote non-stress tests and maternal and fetal heart rate monitoring today while pioneering new data-driven personalized pathways that Nuvo believes will help improve future health outcomes for all expectant mothers and unborn babies.
The stock traded up over 100% in the pre-market after the news yesterday.
The $19 area has acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $21.30, $22.40, $24, $28, $30 and then the pre-market high at $31.97.
Below $19, targets to the downside are $18, $14 and then a gap fill at $10.80.
HSDT - Up over 35% in pre after partnership with LovellĀ® Government Services to expand the reach of PoNS Therapyā¢, a multiple sclerosis(MS) treatment
Helius Medical Technologies Inc. (HSDT) is a neurotechnology company that focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.
In the pre-market this morning, the company announced that it had partnered with Lovell Government Services , an SBA-certified Service Disabled Veteran Owned Small Business , to make the companyās Portable Neuromodulation Stimulator (āPoNSĀ®ā) device available to federal healthcare systems.
Lovell is an approved supplier to the U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) and there are over 28,000 cases of multiple sclerosis (MS) that are reported to the VA annually.
The $8.15 area has acted as resistance in the pre-market and will be an important level to watch.
Above it, the first major target for bulls is the pre-market high at $8.50. Beyond that, $9, $9.50, $10 and $11 come into play.
Below $8.15, targets to the downside are $7.60, $7.42, $7, $6.70, $6 and then a gap fill at $5.66.
3 False Beliefs Most Traders Have
They say it takes BIG $ to make $
They say you need 6 monitors and pricey scanners
They say only day traders can see explosive growth
Results not typical. Trading is hard. Nothing is guaranteed.
Yet with $2k, the same few stocks an indicators Jay has hit 1,947%+ growth in 4.5 months!
KTRA - Up over 100% in pre after entering into a definitive merger agreement with TuHURA Biosciences
Kintara Therapeutics Inc. (KTRA) is a clinical stage drug development company that focuses on developing and commercializing anti-cancer therapies to treat cancer patients.
This morning, the company announced that it had entered into a definitive merger agreement with TuHURA Biosciences for an all-stock transaction forming a company with expertise and resources to advance a risk diversified late-stage oncology pipeline.
TuHURA is planning to advance a single Phase 3 trial for IFx-2.0 personalized cancer vaccine as adjunctive therapy with KeytrudaĀ® in first-line therapy for advanced Merkel cell carcinoma in 2H 2024 under FDA's accelerated approval pathway
$31 million subscribed financing by TuHURA in connection with the merger agreement is expected to provide cash runway into late 2025
The combined company is expected to operate under the name "TuHURA Biosciences, Inc." and to trade on The Nasdaq under the ticker "HURA". The transaction is expected to close in the third quarter of 2024.
KTRA traded up over 100% in the pre-market after the news.
The $0.20 area has acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $0.22, $0.2330, $0.24 and then the pre-market high at $0.2567. Beyond that, $0.2948 comes into play.
Below $0.20, targets to the downside are $0.1670, $0.12, and then a gap fill at $0.1004.
MARKET NEWS š°
P.S. Make sure you text āRAGEā to (888) 404-5747 to get all of our latest HOT STOCK ideas!
Questions or concerns about our products? Email [email protected] Ā© Copyright 2022, RagingBull
DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneysā fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneysā fees, costs and disbursements in addition to any other relief to which it may be entitled.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
Reply